AVECTAS LIMITED – Trademark Portfolio
Entity Type: 99
AVECTAS LIMITED holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include AVECTAS and SOLUPORE. The owner is based in SOUTH DUBLIN 2.
34 FITZWILLIAM SQUARE
SOUTH DUBLIN 2 , IE
Showing of trademarks Trademarks
Trademark Classifications
AVECTAS LIMITED's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does AVECTAS LIMITED have?
AVECTAS LIMITED has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 2 cancelled.
What trademark classes does AVECTAS LIMITED file in?
AVECTAS LIMITED files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are AVECTAS LIMITED's most well-known trademarks?
AVECTAS LIMITED's registered trademark portfolio includes well-known marks such as AVECTAS and SOLUPORE. These are among 3 currently registered trademarks in the portfolio.
What is AVECTAS LIMITED's trademark registration success rate?
AVECTAS LIMITED has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.